Rita Macedo - Infectious Diseases

Author Information

Rita Macedo is affiliated with the National Reference Laboratory for Mycobacteria, Department of Infectious Diseases, at the National Institute of Health in Lisbon, Portugal. Her research primarily focuses on infectious diseases, with a particular emphasis on tuberculosis and related mycobacterial infections. Her work is pivotal in understanding the dynamics of these diseases, especially within the context of Portugal and Portuguese-speaking countries.

Research Contributions

Rita Macedo has contributed significantly to the field of infectious diseases through her extensive research on tuberculosis and non-tuberculous mycobacteria. Her studies have explored various aspects of the diseases, including epidemiology, transmission dynamics, and resistance patterns. Notably, she has investigated the early dynamics of the SARS-CoV-2 epidemic in Portugal, trends in nontuberculous mycobacteria, and the challenges posed by multidrug-resistant and extensively drug-resistant tuberculosis. Her research efforts have provided valuable insights into public health implications, particularly in the management and control of tuberculosis in Portugal and beyond.

Aliases

Rita Macedo is also known by the aliases R Macedo and R. Macedo in academic publications.

Publication and Citation Metrics

Metric	Value
Citation Count	1347
H-index	14
Paper Count	46

Publications:

SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal

DOI: 10.1038/s43856-022-00072-0

Year: 2022

Nontuberculous Mycobacteria in Portugal: Trends from the last decade.

DOI: 10.1016/j.pulmoe.2022.01.011

Year: 2022

LTBI - MDR/XDR-TB cases - should all be treated?

DOI: 10.1183/13993003.congress-2021.pa3344

Year: 2021

Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort.

DOI: 10.1016/j.bj.2021.07.006

Year: 2021

Animal-to-human transmission of Mycobacterium pinnipedii

DOI: 10.1183/13993003.00371-2020

Year: 2020

Poly-resistant tuberculosis outbreak in Northern Portugal: a nine year tale.

DOI: 10.1016/j.pulmoe.2020.02.006

Year: 2020

An outbreak of extensively drug-resistant tuberculosis among a Portuguese family

DOI: 10.1183/13993003.congress-2020.469

Year: 2020

Trends of multidrug-resistant tuberculosis clustering in Portugal

DOI: 10.1183/23120541.00151-2018

Year: 2019

Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries

DOI: 10.1016/j.meegid.2018.03.011

Year: 2019

Insights on the Mycobacterium tuberculosis population structure associated with migrants from Portuguese-speaking countries over a three-year period in Greater Lisbon, Portugal: Implications at the public health level.

DOI: 10.1016/j.meegid.2019.03.025

Year: 2019

What Is the Prognosis for Individuals with Immunodeficiency Disorders?

What Challenges Does HTS Face?

How to ensure the reliability of RT-PCR results?

What is MMR?

How Effective Are Insecticides?

Why is it Important in Infectious Diseases?

What are the best practices for insect bite prevention?

What are the Benefits of Gene Therapy and Immunotherapy?

What Are the Symptoms of Fungal Respiratory Infections?

How Can Rabies Be Prevented?

Partnered Content Networks

Relevant Topics